Corporate Compliance

OIG reviews relationship between Medicare Part D payments and drug acquisition costs

Healthcare Auditing Weekly, January 22, 2008

Medicare Part D payment, not including the dispensing fee, exceeded community pharmacies' drug acquisition costs by an estimated 18 % when drug rebates were included, according to an OIG audit report.

Without the rebates, Part D payments exceeded drug acquisition costs by an estimated 17%. The OIG conducted the review at the request of 33 Senators.

The OIG recommend that Congress and CMS consider the results of the review in any deliberations regarding Medicare Part D reimbursement.

Comments

0 comments on “OIG reviews relationship between Medicare Part D payments and drug acquisition costs

 

    Strategies for Health Care Compliance
  • Strategies for Health Care Compliance

    News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...

  • Compliance Monitor

    This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...

  • Medicare Weekly Update

    Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...

  • Medicare Update for Physician Services

    Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...

Most Popular

Related Articles